In Vitro and in Vivo Activities of Rifampin, Streptomycin, Amikacin, Moxifloxacin, R207910, Linezolid, and PA-824 Against Mycobacterium Ulcerans

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.00052-06
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology